论文部分内容阅读
本刊讯 国家食品药品监督管理局最近批准首个治疗非典药物———西维来司钠 (SivelestatSodium)转归生产前报批阶段 ,进入临床研究。西维来司钠为蛋白酶抑制剂 ,其可改善急性肺部损伤者的呼吸功能 ,是国家启动药品快速审批通道后第一个被批准治疗非典的新药。西维来司钠可抑制
Our newsletter SFDA recently approved the first treatment of SARS - Sivelestat Sodium to be brought to the pre-production approval stage for clinical research. Sildenafil is a protease inhibitor that improves respiratory function in acute lung injury and is the first new drug to be approved to treat atypical pneumonia after the country started the rapid drug approval channel. Sildenafil inhibited